Malignant Peritoneal Neoplasm Completed Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00856180Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian MalignanciesTreatment
NCT00267696Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal CancerTreatment
NCT00343044Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn CancersTreatment